CD40 and atherosclerosis: While the studies presented herein were done in vitro, our findings raise the possibility that CD40-mediated CX3CL1 upregulation in endothelial cells may be relevant in vivo by promoting monocyte recruitment during atherosclerosis or arterial injury-driven neointima formation.